Literature DB >> 15342946

Isolation of a highly clonogenic and multipotential subfraction of adult stem cells from bone marrow stroma.

Jason R Smith1, Radhika Pochampally, Anthony Perry, Shu-Ching Hsu, Darwin J Prockop.   

Abstract

Attempts have been made to develop cell and gene therapies using the adult stem cells from bone marrow referred to as mesenchymal stem cells or marrow stromal cells (MSCs). However, the results have been variable in part because there are no standardized protocols for preparing and characterizing MSCs. In the experiments presented here, we developed a standardized assay by light scattering to measure the content of rapidly self-renewing cells (RS cells) in preparations of MSCs. The assay quickly identifies preparations of MSCs that replicate rapidly in subsequent culture. In addition, the standardized assay enabled us to isolate RS cells that were up to 90% clonogenic and that generated single cell-derived colonies that differentiated into either mineralizing cells or adipocytes with appropriate additions to the medium.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15342946     DOI: 10.1634/stemcells.22-5-823

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  77 in total

1.  Stem cells and aging: a chicken-or-the-egg issue?

Authors:  Johanna A Smith; René Daniel
Journal:  Aging Dis       Date:  2012-02-13       Impact factor: 6.745

2.  Sox11 is expressed in early progenitor human multipotent stromal cells and decreases with extensive expansion of the cells.

Authors:  Benjamin L Larson; Joni Ylostalo; Ryang H Lee; Carl Gregory; Darwin J Prockop
Journal:  Tissue Eng Part A       Date:  2010-07-13       Impact factor: 3.845

3.  Isolation of functionally distinct mesenchymal stem cell subsets using antibodies against CD56, CD271, and mesenchymal stem cell antigen-1.

Authors:  Venkata Lokesh Battula; Sabrina Treml; Petra M Bareiss; Friederike Gieseke; Helene Roelofs; Peter de Zwart; Ingo Müller; Bernhard Schewe; Thomas Skutella; Willem E Fibbe; Lothar Kanz; Hans-Jörg Bühring
Journal:  Haematologica       Date:  2008-12-09       Impact factor: 9.941

Review 4.  Genomic profiling of mesenchymal stem cells.

Authors:  Danijela Menicanin; P Mark Bartold; Andrew C W Zannettino; Stan Gronthos
Journal:  Stem Cell Rev Rep       Date:  2009-02-18       Impact factor: 5.739

5.  Mesenchymal stem cells: from biology to clinical use.

Authors:  Mauro Krampera; Massimo Franchini; Giovanni Pizzolo; Giuseppe Aprili
Journal:  Blood Transfus       Date:  2007-07       Impact factor: 3.443

6.  Amniotic fluid stem cells produce robust mineral deposits on biodegradable scaffolds.

Authors:  Alexandra Peister; Eric R Deutsch; Yash Kolambkar; Dietmar W Hutmacher; Robert E Guldberg
Journal:  Tissue Eng Part A       Date:  2009-10       Impact factor: 3.845

Review 7.  Repair of tissues by adult stem/progenitor cells (MSCs): controversies, myths, and changing paradigms.

Authors:  Darwin J Prockop
Journal:  Mol Ther       Date:  2009-03-31       Impact factor: 11.454

8.  Stem cell research and clinical development in tendon repair.

Authors:  Paola Filomeno; Victor Dayan; Cristina Touriño
Journal:  Muscles Ligaments Tendons J       Date:  2012-10-16

9.  Identification and isolation of small CD44-negative mesenchymal stem/progenitor cells from human bone marrow using elutriation and polychromatic flow cytometry.

Authors:  Sean R R Hall; Yajuan Jiang; Elizabeth Leary; Greg Yavanian; Sarah Eminli; David W O'Neill; Wayne A Marasco
Journal:  Stem Cells Transl Med       Date:  2013-07-11       Impact factor: 6.940

10.  The CD34-like protein PODXL and alpha6-integrin (CD49f) identify early progenitor MSCs with increased clonogenicity and migration to infarcted heart in mice.

Authors:  Ryang Hwa Lee; Min Jeong Seo; Andrey A Pulin; Carl A Gregory; Joni Ylostalo; Darwin J Prockop
Journal:  Blood       Date:  2008-09-25       Impact factor: 22.113

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.